Eudesmane derivatives from Laggera pterodonta
Xiao, YC; Zheng, QX; Zhang, QJ; Sun, HD; Gueritte, F; Zhao, Y
2003-07-01
发表期刊FITOTERAPIA
ISSN0367-326X
卷号74期号:5页码:459-463
摘要A new eudesmane derivative, 4alpha,5alpha-dihydroxyeudesma-11(13)-en-12-oic acid, was isolated from Laggera pterodonta. Its structure was elucidated as (1) on the basis of spectroscopic evidence. Moreover, six known compounds were isolated: pterodontriol A (2), pterodontriol. B, pterodonta acid (3), ilicic acid (4), costic acid and beta-amyrin. Cytotoxic activity of compounds 2, 3 and 4 was investigated. (C) 2003 Elsevier Science B.V. All rights reserved.
关键词Laggera Pterodonta Cytotoxic Activity 4 Alpha 5 Alpha-dihydroxyeudesma-11(13)-en-12-oic Acid
学科领域Chemistry, Medicinal ; Pharmacology & Pharmacy
DOI10.1016/S0367-326X(03)00106-0
收录类别SCI
语种英语
WOS研究方向Pharmacology & Pharmacy
WOS类目Chemistry, Medicinal ; Pharmacology & Pharmacy
WOS记录号WOS:000183917300007
引用统计
被引频次:23[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.kib.ac.cn/handle/151853/4618
专题植物化学与西部植物资源持续利用国家重点实验室
作者单位1.Zhejiang Univ, Coll Pharmaceut Sci, Dept Tradit Chinese Med & Nat Drug Res, Hangzhou 310031, Peoples R China
2.Inst Hangzhou Commerce, Dept Food Sci, Hangzhou 310035, Peoples R China
3.Chinese Acad Sci, Kunming Inst Bot, Kunming 650204, Peoples R China
4.CNRS, ICSN, F-91198 Gif Sur Yvette, France
推荐引用方式
GB/T 7714
Xiao, YC,Zheng, QX,Zhang, QJ,et al. Eudesmane derivatives from Laggera pterodonta[J]. FITOTERAPIA,2003,74(5):459-463.
APA Xiao, YC,Zheng, QX,Zhang, QJ,Sun, HD,Gueritte, F,&Zhao, Y.(2003).Eudesmane derivatives from Laggera pterodonta.FITOTERAPIA,74(5),459-463.
MLA Xiao, YC,et al."Eudesmane derivatives from Laggera pterodonta".FITOTERAPIA 74.5(2003):459-463.
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
201202240048.pdf(70KB) 开放获取--请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Xiao, YC]的文章
[Zheng, QX]的文章
[Zhang, QJ]的文章
百度学术
百度学术中相似的文章
[Xiao, YC]的文章
[Zheng, QX]的文章
[Zhang, QJ]的文章
必应学术
必应学术中相似的文章
[Xiao, YC]的文章
[Zheng, QX]的文章
[Zhang, QJ]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。